Anticipated shortage
TYKERB lapatinib 250mg (as ditosilate monohydrate) tablet bottle
lapatinib ditosilate monohydrate · 405 mg Tablet, film coated
- Supply impact started
- 15 Nov 2026
- Supply impact ends
- 1 Dec 2026
- TGA row last updated
- 6 Nov 2026
- ARTG ID
- 185997
- Sponsor
- Novartis Pharmaceuticals Australia Pty Ltd
- Sponsor phone
- 1800 671 203
- Shortage impact
- Critical
- Availability
- Available
Reason reported to TGA
Manufacturing
TGA management action
An overseas registered product has been approved for supply under Section 19A. See the website and search for the active ingredient: https://www.tga.gov.au/resources/section-19a-approvals
What to do
- 1.Check your current supply — Ask your pharmacist whether you should collect a current prescription before the anticipated shortage.
- 2.Speak with your prescriber — Discuss options before supply is interrupted.
- 3.Watch the TGA report — Anticipated shortages can change before the supply impact starts.
Official sources
Last updated from the TGA Medicine Shortage Reports Database (report generated 12 November 2026 10:24:39 PM).
MedWatch is for informational purposes only and does not constitute medical advice. Never stop or change your medicines without consulting your doctor or pharmacist. In an emergency, call 000. Medication queries: National Medicines Line 1300 633 424.